文献速递神经介入DSA

超短血流导向装置治疗颅内动脉瘤:技术可行性、造影结局与临床安全性

Very short flow diverters for intracranial aneurysms: technical feasibility, angiographic outcomes, and clinical safety across diverse cerebrovascular locations.
PubMed 文献 · Neuroradiology · 2026-10-30

单中心回顾性队列纳入75例患者151个动脉瘤,86个索引动脉瘤使用93枚10-12 mm超短血流导向装置,技术成功率为95.3%(82/86),平均随访15.2个月时影像随访亚组完全闭塞率85.7%、充分闭塞率100%,永久性神经并发症发生率6.7%。装置异位仅见于大脑中动脉区域且均为释放过近端,提示经验操作者由远及近释放至关重要。

要点

  • 超短FD技术成功率高,但装置异位均见于大脑中动脉且为释放过近端。
  • 影像随访亚组完全闭塞率85.7%、充分闭塞率100%,需注意失访偏倚。
  • 术后永久性神经并发症发生率6.7%,随访期内无需再治疗。

核心结论

  • 超短血流导向装置在选定的颅内动脉瘤中技术可行,但是否优于常规长度装置未经检验,需解剖匹配比较。

研究设计与样本

  • 单中心回顾性队列研究,纳入75例患者151个动脉瘤,86个索引动脉瘤使用93枚10-12 mm超短血流导向装置。
  • 主要结局为技术成功,定义为索引术中预期超短FD跨越瘤颈释放且瘤颈完全覆盖,按索引动脉瘤分析。
  • 次要结局包括采用O'Kelly-Marotta(OKM)分级评估的造影结果和随访改良Rankin量表(mRS)评估的临床结局。

诊断标准与关键数值

  • 技术成功率为95.3%(82/86索引动脉瘤),其余4个因第一枚装置异位需第二枚装置。
  • 平均随访15.2±11.0个月,影像随访亚组(49例)完全闭塞率85.7%(42/49),充分闭塞率100%(49/49)。
  • 临床随访亚组(61例)良好临床结局(mRS 0-2)率为83.6%(51/61),随访期内无需再治疗。
  • 术后永久性神经并发症发生率为6.7%(5/75)。
  • 75例中26例(34.7%)无影像随访,上述影像结局比例仅适用于影像随访亚组。

临床应用与阅片要点

  • 使用超短FD时建议由经验操作者从远端向近端释放,以避免装置释放过近端导致异位。
  • 装置异位仅见于大脑中动脉区域,该部位释放时需格外注意位置确认。
  • 报告影像随访结果时应注明仅基于影像随访亚组,避免外推至全部治疗患者。

局限性

  • 单中心回顾性设计,样本量有限,结果需外部验证。
  • 34.7%患者无影像随访,影像结局比例仅适用于影像随访亚组,存在失访偏倚。
  • 未与常规长度血流导向装置进行解剖匹配比较,无法评价超短FD的相对优势。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Longer flow diverters (FDs) are often selected to facilitate deployment. Very short FDs (VSFDs; 10-12 mm) offer a targeted alternative, but technical complexity has limited their adoption, resulting in scarce clinical data.

METHODS: This single-center, retrospective cohort study included patients with intracranial aneurysms who underwent VSFD treatment. The primary outcome was technical success, defined as deployment of the intended VSFD across the aneurysm neck with complete neck coverage at the end of the index procedure, and analyzed per index aneurysm. Secondary outcomes included angiographic results, assessed using the O'Kelly-Marotta (OKM) grading scale, and clinical outcomes, evaluated with the modified Rankin Scale (mRS) during follow-up. Statistical analyses were performed using R software (version 4.5.2; R Foundation for Statistical Computing, Vienna, Austria).

RESULTS: Seventy-five patients harboring 151 aneurysms were included, with 86 index aneurysms treated using 93 VSFDs. Technical success was achieved in 82 of 86 index aneurysms (95.3%); the remaining 4 aneurysms required a second device because of malposition of the first. At a mean follow-up of 15.2 ± 11.0 months, complete occlusion was achieved in 42 of 49 patients with imaging follow-up (85.7%) and adequate occlusion in 49 of 49 (100%); imaging follow-up was unavailable in 26 of 75 patients (34.7%), so these proportions apply to the imaged subgroup only. Favorable clinical outcome (mRS 0-2) was obtained in 51 of 61 patients with clinical follow-up (83.6%), and no retreatment was required during follow-up. Postprocedural permanent neurological complications occurred in 5 of 75 patients (6.7%).

CONCLUSIONS: VSFDs were technically feasible in selected intracranial aneurysms. Whether they offer any advantage over conventional-length devices was not tested in this study and requires anatomically matched comparison. Device malposition occurred only in the middle cerebral artery territory, and in every case the device had been deployed too proximally, so deployment from distal to proximal by experienced operators is essential.

来源:Neuroradiology,查看原文。版权归原作者所有。

引用

  1. Çınar, Elek, Kıran, et al. Very short flow diverters for intracranial aneurysms: technical feasibility, angiographic outcomes, and clinical safety across diverse cerebrovascular locations. Neuroradiology. 2026. PMID: 42961457. doi:10.1007/s00234-026-04235-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。